Ibogaine References:Alper K, et al. Ibogaine: Scientific Literature Overview. International Center for Ethnobotanical Education. 2012. Available at: chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://www.iceers.org/Documents_ICEERS_site/Scientific_Papers/ibogaine/ICEERS2012_Ibogaine_literature_compilation.pdfCorkery JM. Ibogaine as a Treatment for Substance Misuse: Potential Benefits and Practical Dangers. Progress in Brain Research. 2018(242);...
Ibogaine References:
Alper K, et al. Ibogaine: Scientific Literature Overview. International Center for Ethnobotanical Education. 2012. Available at: chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://www.iceers.org/Documents_ICEERS_site/Scientific_Papers/ibogaine/ICEERS2012_Ibogaine_literature_compilation.pdf
Corkery JM. Ibogaine as a Treatment for Substance Misuse: Potential Benefits and Practical Dangers. Progress in Brain Research. 2018(242); 217-257. https://www.sciencedirect.com/science/article/abs/pii/S0079612318300979?via%3Dihub
Dalton C. A Detox Drug Promises Miracles if it Doesn’t Kill You First. Wired. 15 Sept 2019. https://www.wired.com/story/a-detox-drug-promises-miraclesif-it-doesnt-kill-you-first/
Davis AK, et al. Subjective Effectiveness of Ibogaine Treatment for Problematic Opioid Consumption: Short and Long Term Outcomes and Current Psychological Functioning. Journal of Psychedelic Studies. 2017. https://akjournals.com/view/journals/2054/1/2/article-p65.xml
Kock P, et al. A Systematic Literature Review of Clinical Trials and Therapeutic Applications of Ibogaine. Journal of Substance Abuse Treatment. 2022. https://www.sciencedirect.com/science/article/pii/S0740547221004438
Mash D. Breaking the Cycle of Opioid Use Disorder. Multi-Disciplinary Association of Psychedelic Studies convention. Presented 22 June 2023. Accessed 17 Dec 2023.
Mash D, et al. Ibogaine Detoxification Transitions Opioid and Cocaine Users between Dependence and Abstinence: Clinical Observations and Treatment Outcomes. Frontiers in Pharmacology. 2018. https://www.frontiersin.org/articles/10.3389/fphar.2018.00529/full
Mash D and Luz M. Evaluating the toxicity and therapeutic potential of ibogaine in the treatment of chronic opioid abuse. Drug Metabolism and Toxicology. 2021. https://www.tandfonline.com/doi/full/10.1080/17425255.2021.1944099
Oaklander M. Inside Ibogaine: One of the most Promising and Perilous Psychedelics for Addiction. Time Magazine. 5 April 2021. https://time.com/5951772/ibogaine-drug-treatment-addiction/
Popik P, et al. Pharmacology of Ibogaine and Ibogaine Related Alkaloids. Progress in Brain Research. 2018.
Siebert A. Kentucky Summit to Explore Ibogaine Treatment for Opioid Use Disorder. Forbes. 17 Nov 2023. https://www.forbes.com/sites/amandasiebert/2023/11/17/kentucky-summit-to-explore-ibogaine-treatment-for-opioid-use-disorder/
GLP-1 references (discussed in intro):
Could Obesity Drugs Take a Bite out of the Food Industry? Morgan Stanley. 5 Sept 2023. https://www.morganstanley.com/ideas/obesity-drugs-food-industry
Lilly’s Zepbound Achieved Additional 6.7% Weight Loss….[press release]. Associated Press. 11 Dec 2023.
Thompson D. The Weight Loss Drug Revolution Part 1. Plain English [podcast], The Ringer podcast network. Aired 12 Dec 2023.
Colby Burns, PharmD, MBA
Chris Toney, PharmD
View more
